The expression of eukaryotic genes is regulated at multiple levels to control the production of functional proteins at the appropriate amount, location and time in different cell types. The modulation of mRNA levels by targeted degradation is a widespread mechanism to downregulate gene expression post-transcriptionally. Several pathways mediate the depletion of the translatable pool of physiological and nonphysiological transcripts (reviewed in refs. 1,2). NMD was originally discovered as the surveillance pathway that detects and degrades mRNAs with PTCs (reviewed in refs. 3, 4) . These aberrant mRNAs arise frequently because of germline mutations in inherited genetic disorders, pre-mRNA processing errors and nonproductive rearrangements at the DNA or RNA level (reviewed in refs. 5,6). NMD also modulates the steady-state level of physiological mRNAs, amounting to ~10% of the transcriptome (reviewed in ref. 7).
a r t i c l e s
The expression of eukaryotic genes is regulated at multiple levels to control the production of functional proteins at the appropriate amount, location and time in different cell types. The modulation of mRNA levels by targeted degradation is a widespread mechanism to downregulate gene expression post-transcriptionally. Several pathways mediate the depletion of the translatable pool of physiological and nonphysiological transcripts (reviewed in refs. 1,2). NMD was originally discovered as the surveillance pathway that detects and degrades mRNAs with PTCs (reviewed in refs. 3, 4) . These aberrant mRNAs arise frequently because of germline mutations in inherited genetic disorders, pre-mRNA processing errors and nonproductive rearrangements at the DNA or RNA level (reviewed in refs. 5, 6) . NMD also modulates the steady-state level of physiological mRNAs, amounting to ~10% of the transcriptome (reviewed in ref. 7) .
The NMD pathway is evolutionary conserved in eukaryotes and essential in humans (reviewed in ref. 8) . Work in different model organisms has shown that NMD requires translating ribosomes and a combination of cis-acting elements and trans-acting factors to signal whether the context of translation termination is physiological or aberrant 9, 10 . Cis-acting elements can originate from the 3′ untranslated region (UTR), whose length and features influence the process of translation termination (the 'faux 3′ UTR' model) 9, 11, 12 . In addition, a major determinant that promotes NMD in human cells derives from splice junctions 3, 4 . Here, four proteins assemble onto mRNA upon splicing to form the EJC, a stable constituent of the spliced mRNP 13 . In humans, NMD is elicited when a stop codon is present at least 50-54 nucleotides (nt) upstream of a splice junction. This observation, made decades ago, is now interpreted in molecular terms as the requirement of a minimal distance for a ribosome stalled at a PTC to establish the appropriate network of interactions with a downstream EJC. Although this mechanism was originally thought of as a specialization to increase the efficiency of NMD in vertebrates, EJC-mediated NMD has recently also been discovered in flies 14 .
The cross-talk between the terminating ribosome and the EJC is mediated by the trans-acting factors UPF1 (also known as SMG2 and RENT1), UPF2 (also known as SMG3) and UPF3 (also known as SMG4). UPF1 is an RNA helicase that associates with ribosomes via interaction with release factors [15] [16] [17] . The catalytic activity of UPF1 is essential for NMD and is triggered upon formation of the surveillance complex [18] [19] [20] . The switch from 'off ' to 'on' state is mediated by a conformational change that occurs upon binding of UPF2, a multidomain protein that concomitantly binds UPF3 (refs. 20,21) . Although these features are conserved from yeast to humans, the choreography of interactions centered at the UPF complex is markedly more complex in metazoans. In humans, UPF3 contains a C-terminal low-complexity region that binds to the EJC 22, 23 . UPF1 also contains N-terminal and C-terminal low-complexity regions that are phosphorylated upon formation of the surveillance complex by the SMG1 kinase in conjunction with its regulators SMG8 and SMG9 (refs. 24-27) . UPF1 phosphorylation is thought to induce translational repression 28 , cause dissociation from the ribosome 25 and recruit downstream trans-acting factors (SMG6 and SMG5-SMG7) 29 , eventually leading to mRNA degradation. Additional layers of complexity have also been reported, including interaction of UPF1 with the mRNA 5′ end 30 and with the 3′ UTR 31 , as well as alternative pathways 32 .
According to the prevalent model, formation of the UPF surveillance complex in human cells occurs when UPF2-UPF3 bound to an EJC comes close to UPF1 bound to a terminating ribosome.
After dissociation from the ribosome, the UPF1 helicase is thought to move along the nucleic acid in the 5′→3′ direction, stripping the proteins bound to it and disassembling the downstream mRNP 33 . How is the UPF complex formed on the EJC such that it can elicit helicase activity toward the 3′ end of the mRNP? Partial structural information from X-ray crystallography of the EJC 23, 34, 35 and of UPF proteins and subcomplexes 21, [36] [37] [38] is available, but how these components are pieced together in the surveillance complex is unknown. This is partly because it is difficult to obtain structural information about intermediates in transient macromolecular complexes formed by structured and unstructured regions. In this study, we produced and stabilized the heptameric UPF-EJC complex biochemically; we report its cryo-EM structure at a resolution of 16 Å. We have interpreted the cryo-EM reconstruction on the basis of available atomic models and additional structural, MS and biochemical data.
RESULTS

Purification of chemically homogeneous UPF-EJC complexes
The domain structure of individual UPF proteins is known from earlier structural studies and from computational predictions (Fig. 1a) . Human UPF1 has a folded core (residues 115-914) that contains a regulatory zinc-knuckle domain (the CH domain) and the catalytic helicase region (formed by domains 1B, 1C, RecA1 and RecA2). The low-complexity N-and C-terminal regions are not involved in binding UPF or EJC proteins 20 and were not included in this study. The CH domain of UPF1 binds UPF2, a 147-kDa protein with three predicted middle domain of eukaryotic initiation factor 4G (MIF4G) domains as well as regions with limited secondary structure (particularly at the N and C termini; Fig. 1a ). The C-terminal region of UPF2 contains the main binding determinant for UPF1, as has been shown both biochemically 20, 39 and with structural studies 38 . The third MIF4G domain (MIF4G 3 ) binds UPF3. The interacting region of UPF3 is a domain with the fold of an RNA-recognition motif (RRM) 36 . Human UPF3 also contains a C-terminal low-complexity region that is not required to form the UPF complex 20 , but contains the EJC-binding motif (EBM) 22, 23 . The EJC core is formed by MAGO, the RRM domain of Y14, eIF4AIII, a low-complexity region of Barentsz (Btz) (the SELOR domain, residues 137-286), RNA and ATP 34, 35, 40 .
We purified the human EJC core, UPF1 115-914 (referred to below as UPF1), full-length UPF2 and one of the variants of UPF3 (UPF3b, also known as UPF3X) as described 21, 23 . The individual recombinant components were combined to reconstitute and purify the UPF1-UPF2-UPF3-EJC complex by size-exclusion chromatography (Supplementary Fig. 1a) . To facilitate the interpretation of the EM maps, we also purified the UPF2-UPF3-EJC and UPF1-UPF2-UPF3 RRM complexes. Despite the presence of low-complexity regions, we obtained samples of these multisubunit complexes with relatively high chemical homogeneity and in amounts suitable for structural studies (Fig. 1b) .
Stabilization of structurally homogeneous UPF-EJC
The UPF1-UPF2-UPF3-EJC complex was stable at protein concentrations used for biochemical reconstitutions (~25 µM) but dissociated at the low concentrations required in EM analysis to prevent contacts between individual molecules (about 0.05-0.2 µM; data not shown). We proceeded by stabilizing UPF1-UPF2-UPF3-EJC using the GraFix method, a sample preparation procedure for EM single-particle analysis that involves mild and gradual chemical fixation during sucrose gradient centrifugation 41 . We evaluated the cross-linked particles that sedimented in each fraction of the gradient according to their size and content. Two fractions showed a sharp, well-defined band in SDS-PAGE (fractions f7 and f8, Supplementary Fig. 1b,c) .
Negative-stain EM of the cross-linked samples that migrated with higher apparent molecular mass in SDS-PAGE showed the presence of large aggregates (f5 and f6, data not shown). Samples of lower apparent molecular mass (f8 and f9) contained heterogeneous particles of small size, indicating complex dissociation. The sample selected for subsequent EM analysis (f7) showed monodisperse particles that were homogeneous in size and shape ( Supplementary Fig. 2a,b) . We used a similar procedure to assess the content and quality a UPF1 The three complexes used in the structural analysis migrated by SDS-PAGE as we expected on the basis of their relative molecular mass (Fig. 1c) . Finally, we probed the three cross-linked complexes by MS (discussed below) and by western blotting using antibodies to the EJC subunit eIF4AIII and UPF subunits. The results confirmed the protein composition we expected: we detected eIF4AIII only in the UPF1-UPF2-UPF3-EJC and UPF2-UPF3-EJC samples (Fig. 1d, left) , UPF1 only in the UPF1-UPF2-UPF3-EJC and UPF1-UPF2-UPF3 RRM samples (Fig. 1d , right) and UPF2 in all three samples (Fig. 1d , middle).
Cryo-EM structure of the UPF1-UPF2-UPF3-EJC complex
To generate a starting model suitable for cryo-EM reconstructions, we first analyzed the UPF1-UPF2-UPF3-EJC complex in negative stain. We obtained an ab initio model with the random conical tilt (RCT) method 42 and used it as reference for the refinement of >10,000 individual images ( Fig. 2a and Supplementary Figs. 2b and 3). The resulting structure at a resolution of 32 Å showed an elongated particle with a bulky density region (referred to as 'head') connected to a thinner region (the 'foot'; Fig. 2a ). We next examined the location of UPF1 and of the EJC in the complex by determining and comparing the negative-stain structures of complexes missing either of these components. In the case of UPF2-UPF3-EJC, the negative-stain images showed a shorter particle as compared with the intact complex (Fig. 2b, top) . The 3D structure of UPF2-UPF3-EJC showed that the foot region was missing (Fig. 2b , bottom), as we also observed by calculating the difference between 2D averages of the full complex and UPF2-UPF3-EJC (Fig. 2b, insert) . In the case of the UPF1-UPF2-UPF3 RRM complex, the difference between 2D averages as well as the 3D structure showed that a portion of the head was missing as compared with the intact complex ( Fig. 2c) . Thus, the difference maps located UPF1 at the foot and the EJC within the head, at opposite ends of the complex. With the exception of the missing portions, the EM reconstructions of three complexes had markedly similar features ( Fig. 2a-c) .
We used the negative-stain structure of UPF1-UPF2-UPF3-EJC as a reference template to start the angular refinement of images obtained from unstained frozen samples (Supplementary Fig. 3 ). We processed >85,000 unstained particles to obtain a cryo-EM structure of UPF1-UPF2-UPF3-EJC, estimated at a resolution of 16 Å (using a Fourier shell correlation criterion of 0.5; Fig. 2d ). The cryo-EM map showed the overall features of the corresponding negative-stain map but with higher resolution and greater details (Fig. 2e) . The cryo-EM map showed that the foot has a bilobal shape and the head contains a distorted ring-like structure at the front connected to a compact density at the back end (Fig. 2e) . The ring-like structure is also connected to the foot. We obtained a pseudoatomic model for the three-dimensional architecture of the UPF1-UPF2-UPF3-EJC surveillance complex by fitting known atomic structures or homology models according to the features of the map and to the topological information obtained from additional negative-stain EM reconstructions, as well as from MS and biochemical data (discussed below).
The helicase region is exposed in the UPF-EJC complex
We first docked UPF1 to the foot (Fig. 3) , the region where we had localized it by comparing the UPF1-UPF2-UPF3-EJC and the UPF2-UPF3-EJC negative-stain reconstructions (Fig. 2b) . In the cryo-EM map, the foot comprises a larger lobe (~45 Å in diameter) and a smaller lobe (~30 Å in diameter). In the crystal structure of UPF1 bound to the C-terminal domain of UPF2 (UPF1-UPF2 Cterm ), the helicase region is organized in two modules, a smaller module encompassing the RecA2 domain and a larger one encompassing the RecA1, 1B and 1C domains 38 . The two modules are in an open conformation compared with the closed conformation that is induced upon RNA binding 21 . We docked the atomic coordinates of UPF1-UPF2 Cterm such that the RecA1-1B-1C and RecA2 modules fit into the large and small lobes of density of the cryo-EM map, respectively a r t i c l e s (cross-correlation = 0.71). In this model, the CH domain and UPF2 Cterm fit into the density of the ring-like structure, but parts of domains RecA1 and 1C in the helicase region were outside the density of the EM map (Supplementary Fig. 4a ). We independently validated this model by labeling the UPF-EJC complex with an antibody recognizing residues 250-300 of UPF1 (in the CH domain). The antibody labeled a region of the ring compatible with the model (Fig. 4a) .
The fit of UPF1 within the foot could be improved by a small rigid-body movement of the entire helicase region such that only a portion of domain 1B would be out of the density (a domain known to assume different conformations in different crystal structures of UPF1; refs. 21,37,38; cross-correlation = 0.73) and concomitantly by a rotation of the CH domain relative to the helicase region (crosscorrelation = 0.88; Fig. 3 and Supplementary Fig. 4b) . Movement of the CH domain relative to the helicase region would be feasible in the context of earlier structural information 21, 38 . Independent of the details of the exact orientation of the CH domain relative to the helicase region, cryo-EM analysis shows that the CH domain is linked to the large lobe (that is, to RecA1, corresponding to an unwinding-competent state). It also shows that the helicase region sticks out from the surveillance complex. The RecA2 domain in particular is not restrained by contacts with other subunits, rationalizing how RNA could access the binding site on UPF1 when the helicase is within the surveillance complex.
UPF2 is a structural ring-like scaffold
We next interpreted the ring-like density that is connected both to the foot (UPF1) and to the back of the head (where we localized the EJC) by fitting the missing folded regions of the UPF complex: the CH domain of UPF1 (~17 kDa), the three MIF4G domains of UPF2 (~90 kDa) and the RRM domain of UPF3 (19 kDa; Figs. 2e and 3). As UPF2 is the largest component of the three, we hypothesized that it accounts for most of the ring-like density. To validate this, we investigated the non-cross-linked negative-stain structure of UPF2. Single molecules of UPF2 appeared in negative-stain EM as distorted circles, with apparent conformational heterogeneity (Fig. 4b) . We used RCT reconstruction to obtain an ab initio model of UPF2 from homogenous subclasses of images. The resulting structure showed an open Figure 3 Molecular architecture of UPF1-UPF2-UPF3-EJC complex. Three views of cryo-EM structure of UPF1-UPF2-UPF3-EJC fitted with atomic structures of EJC bound to a small fragment of UPF3 and containing a short RNA fragment (black; PDB 2XB2) 23 , of UPF1 bound to the C-terminal domain of UPF2 (PDB 2WJV) 38 , of the C-terminal MIF4G bound to an N-terminal fragment of UPF3 (PDB 1UW4) 36 and of two homology models for MIF4G 1 and MIF4G 2 . Colors are as in Figure 1a . Figure 4 Validation of structural model of UPF-EJC complex. (a) Antibody labeling of UPF-EJC complex using polyclonal antibodies to residues 250-300 of UPF1, residues 100-200 of UPF2, residues 1-50 of UPF3 and eIF4AIII (also used for Fig. 1d ). Two typical labeled complexes for each case together with 2D averages for several images of antibody-UPF-EJC complexes in similar orientations. Using these images and after comparison with the projections from UPF-EJC we inferred a model for each of the immune complexes. Putative location of epitopes recognized by each antibody according to pseudoatomic model is colored in model (UPF1, yellow; UPF2, blue; UPF3, green; eIF4AIII, orange). Images of UPF-EJC and an isolated antibody (Ab) at the same magnification are reference for comparison. (b) EM and structure of UPF2. Top, representative images of particles, projections from structure (P) and 2D averages (A). Bottom, two views of structure of UPF2 in which pseudoatomic model of UPF2 proposed within UPF-EJC complex (Fig. 3) was fitted.
(c) Purification, EM and structure of UPF2-UPF3 complex. Peak fraction of size-exclusion chromatography containing UPF2 and UPF3 (inset, SDS-PAGE of these fractions) was analyzed by EM. Top, representative images of raw particles, projections from structure (P) and 2D averages (A). Bottom, two views of structure of UPF2-UPF3. Structure of UPF2-UPF3 was fitted with atomic model proposed for these proteins in the context of the intact complex (Fig. 3) . (Fig. 4b) .
To fit the available atomic models or homology models into the ring-like density (Fig. 3) , we obtained additional restraints by MS analysis. We treated the UPF1-UPF2-UPF3 RRM cross-linked sample with trypsin and sequenced the peptides resulting from the proteolytic cleavage by ESI-MS analysis (Supplementary Fig. 5 ) 43 . With this approach, only regions of the proteins in which lysine residues have not been modified by glutaraldehyde can be detected; this suggests that they are protected and not accessible to solvent (either because they are in the core of molecule or because they are protected by interactions in the UPF-EJC complex). The comparison of peptides detected for UPF1-UPF2-UPF3 RRM , UPF2-UPF3-EJC and UPF1-UPF2-UPF3-EJC shows exposed regions specifically protected by protein-protein interactions within UPF-EJC. The analysis showed the presence of peptides that we expected from the interaction interfaces in the UPF2 MIF4G 3 -UPF3 RRM crystal structure (UPF3 residues 57-64 and 103-138; Fig. 5 and Supplementary Fig. 5 ; ref. 36 ) and the UPF1-UPF2 Cterm crystal structures (UPF2 residues 1120-1128, 1152-1176 and 1185-1209; Fig. 5 and Supplementary Fig. 5 ; ref. 38) . Through MS analysis, we also detected other peptides in the C and N termini of UPF2 (residues 1215-1246 and 1257-1266; residues 112-137 and 146-163; Supplementary Fig. 5 ). These results indicate that the N-terminal region and almost the entire C-terminal region of UPF2 are buried in the complex, supporting a ring-like architecture of UPF2.
In our model (Fig. 3) , we arranged the three MIF4G domains of UPF2 consecutively in a circular fashion, with the N and C termini approaching each other and the CH domain of UPF1 (cross-correlation MIF4G 1 = 0.88; cross-correlation MIF4G 2 = 0.79; cross-correlation MIF4G 3 = 0.89). This spatial arrangement of the MIF4G domains is consistent with topological features of the proteins and of the cryo-EM density. First, MIF4G 2 and MIF4G 3 are close together as in the primary structure of UPF2. Second, there is sufficient density to accommodate the 200-residue connecting region between MIF4G 1 and MIF4G 2 ( Fig. 1a) and to accommodate the bound UPF3 RRM to MIF4G 3 . This configuration also places the C-terminal end of MIF4G 3 near the N terminus of the UPF2 C-terminal domain (which binds the CH domain in UPF1; Fig. 3) . Notably, the structure of non-cross-linked UPF2 fitted this pseudoatomic model (Fig. 4b) . Although the docking is probably not accurate in detail, the ring-like architecture of UPF2 closed around the CH domain of UPF1 is in agreement with results from earlier coimmunoprecipitation studies showing that deletions at the N and C termini of UPF2 (∆94-133 and ∆1094-1272, respectively) both diminished the interaction with UPF1, albeit to a different extent 39 .
To corroborate this model we used a double strategy. First, residues 100-200 of UPF2 and 1-50 of UPF3 were localized in the images of UPF-EJC by labeling with polyclonal antibodies that were found to bind regions compatible with the model (Fig. 4a) . Second, we analyzed the non-cross-linked negative-stain structure of the UPF2-UPF3 complex (Fig. 4c) . The images of UPF2-UPF3 were slightly larger and less rounded than those of UPF2. The structure of the complex showed a ring with extra densities that fitted the UPF2-UPF3 model proposed from the cryo-EM structure. In the UPF2-UPF3 structure, density for full-length UPF3 outside the RRM domain extends toward the EJC-interacting region. (a) Western blot analysis of UPF1-UPF2-UPF3-EJC complexes, reconstituted with a 15-mer poly(U) ssRNA containing a biotin moiety at the 5′ or 3′ end and bound to streptavidin. (b) Projections (P) and averages (A) for each of labeled complexes. Label is a dense spot in the vicinity of the UPF-EJC complex. (c) Negative-stain structure of UPF1-UPF2-UPF3-EJC (pink) with RNA 3′ end labeled with a biotin moiety bound to streptavidin. Bottom, fitting of cryo-EM structure of UPF1-UPF2-UPF3-EJC (white transparent density) within 3′-labeled complex to facilitate mapping of RNA end. Atomic structure of EJC complex fitted within the cryo-EM reconstruction has same color codes as in Figure 3 . RNA in complex (black) was modeled by extending RNA crystallized with the EJC (PDB 2XB2) 23 . The structure of a streptavidin tetramer (PDB 1MEP) 50 is fitted within the density of the tag (pink). (d) Negative-stain structure of UPF1-UPF2-UPF3-EJC complex with RNA 5′ end with a biotin moiety bound to streptavidin (in green). Bottom, fitting of cryo-EM structure of UPF1-UPF2-UPF3-EJC with a similar representation as for the 3′-labeled complex. Tag is in green at bottom.
npg a r t i c l e s
Connections between UPF3 and the EJC The last element of the UPF1-UPF2-UPF3-EJC cryo-EM map that we interpreted was the compact density at the back end of the head where we had located the EJC from the analysis of the difference density between the UPF1-UPF2-UPF3-EJC and UPF1-UPF2-UPF3 RRM negative-stain maps (Figs. 2 and 3 ). This location was also supported by labeling experiments using antibodies to the EJC subunit eIF4AIII (Fig. 4a) . When rendered at the resolution of the cryo-EM map, the EJC has an overall elliptical shape. Half of the ellipse (including the RecA1 domain of eIF4AIII and the C terminus of the Btz SELOR domain) is slightly smaller than the other half (including MAGO, Y14, the RecA2 domain of eIF4AIII and the N terminus of Btz SELOR). The larger lobe is also where a segment from the C terminus of UPF3 binds 23 . These features pointed to the orientation of the complex in the density, where it could be docked computationally with a cross-correlation coefficient of 0.84 (Supplementary Fig. 6 ). An earlier negative-stain structure of an EJC reconstituted with full-length Btz 44 fits with our cryo-EM map, with an additional density that probably corresponds to regions of Btz outside the SELOR domain (not shown).
The cryo-EM map showed a connection in density between the back of the head (the EJC) and the ring-like structure at the front (UPF2-UPF3), indicating a point of contact. To map the interacting proteins and surfaces, we used the MS approach described above to assess the protection pattern of UPF samples with and without the EJC. The comparative analysis showed no marked differences in UPF2. The only exception was a peptide at the N-terminal side of MIF4G 2 (residues 587-598) that we detected in the UPF1-UPF2-UPF3 RRM and UPF1-UPF2-UPF3-EJC samples, but not in UPF2-UPF3-EJC (Fig. 5) . This indicates that the N-terminal side of MIF4G 2 might change orientation when the UPF2 ring closes upon binding UPF1. The major differences were instead located in UPF3. The EJC-bound samples showed the presence of the EJC-binding motif of UPF3 (residues 422-434, Fig. 5 ) that is known from the EJC-UPF3 Cterm crystal structure to interact with MAGO-Y14 and with the RecA2 domain of eIF4AIII 23 . The analysis of EJC-bound samples also showed additional peptides within the regions of UPF3 preceding and following the RRM domain (residues 14-35, 151-188 and 197-205) , which are therefore buried in the presence of the EJC 23 .
The EJC points the 3′ end of bound RNA toward UPF1
We next investigated how the surveillance complex is oriented onto RNA. In the EJC-UPF3 Cterm crystal structure, the 3′ and 5′ ends of an 8-nt single-stranded RNA (ssRNA) are at the antipodes of the elliptical assembly, protruding from the RecA1 and RecA2 domains, respectively 23 . Thus, the positioning of the RNA ends could be extrapolated from the fitting of the crystal structure in the cryo-EM map of UPF-EJC (Fig. 3) . For an independent validation of the pseudoatomic model, we reconstituted two variants of the EJC using a 15-mer ssRNA labeled with a biotin moiety at either the 3′ or the 5′ end. We assembled the corresponding UPF1-UPF2-UPF3-EJC complexes, coupled them to streptavidin and cross-linked them with the same GraFix procedure used for the untagged complex (Supplementary Fig. 2) . We verified the presence of the streptavidin tag in both cross-linked samples by western blotting (Fig. 6a) .
The negative-stain EM structures of the streptavidin-labeled complexes showed a similar architecture to that of UPF1-UPF2-UPF3-EJC, but with additional density connected to the head (Fig. 6b-d) . We overlaid the negative-stain maps of the streptavidin-labeled complexes onto the cryo-EM map of the unlabeled complex. The fitting was done computationally and showed the additional density (the putative streptavidin tag) in the vicinity of the RecA1 domain of eIF4AIII in the case of the 3′-labeled sample (Fig. 6c, bottom) and near the position corresponding to the RecA2 domain of eIF4AIII in the case of the 5′-labeled sample (Fig. 6d, bottom) . The size of the extra density was what we expected for a streptavidin tetramer (60 kDa) and its distance from the EJC was compatible with the attachment of streptavidin to the 3′ and 5′ ends of the 15-mer biotinylated RNAs used in the biochemical reconstitutions (modeled in Fig. 6c,d , black). In the cryo-EM map, the 3′ end of the RNA embedded in the EJC points toward the small lobe of UPF1 (Fig. 6c, bottom) , where we expected the 5′ end of RNA to bind in the course of the unwinding reaction 21 (Fig. 7) . Modeling of an RNA bound to UPF1 according to known crystal structures 21 within the cryo-EM map of UPF-EJC indicates that the RNA 3′ end in the EJC would be ~80 Å from the RNA 5′ end in UPF1, a distance that would be spanned by a minimum Figure 7 Model of surveillance complex during NMD. Scheme recapitulates some of the most important steps in mammalian NMD, incorporating information from the UPF-EJC cryo-EM structure in a simplified version. Premature translation termination leads to recruitment of UPF1. If the recruitment occurs >30 nt from a downstream UPF2-UPF3-EJC complex, NMD proceeds through recruitment of the SMG1 kinase, UPF1 phosphorylation and binding to UPF2-UPF3-EJC, recruitment of SMG5-SMG7 and SMG6 factors and endonucleolytic cleavage of the mRNA by SMG6. The final stages of NMD involve mRNP remodeling and degradation. The architecture of the surveillance complex places the UPF1 helicase at the appropriate position to remodel the 3′ end of the mRNP (RNA-RNA and RNA-protein interactions, gray sphere). Remodeling of the EJC (at the 5′ end of UPF1) requires ribosome-binding protein PYM. mRNP remodeling allows RNA decay exonucleases (Xrn1 and exosome-Ski) to degrade the body of the nucleic acid. npg a r t i c l e s of 13 nt. With the opposite geometry (that is, if in the surveillance complex UPF1 were positioned at the 5′ end of the EJC), the RNA 3′ end in UPF1 would be ~120 Å from the RNA 5′ end in the EJC. Such distance would be spanned by a minimum of 19 nt and would be incompatible with the 50-nt rule of EJC-dependent NMD, as we discuss below. In the context of the surveillance complex, the UPF1 helicase is thus positioned downstream of the EJC.
DISCUSSION
One of the central steps in the nonsense-mediated mRNA decay pathway is the activation of the UPF1 helicase to remodel the 3′ end of mRNPs undergoing NMD 33 . UPF1 is activated in the context of the surveillance complex with UPF2 and UPF3, whose recruitment in human cells generally depends on the EJC. In this work, we trapped a transient assembly of the NMD pathway, namely the surveillance complex, after its recruitment onto the EJC and before it unlashes its helicase activity toward the 3′ end of the mRNP. It is challenging to obtain structural information on the UPF-EJC complex because of its transient nature. We circumvented this problem by stabilizing the samples with gentle cross-linking, a method successfully used before to overcome the instability of complexes at low concentrations 41, 45 . Several observations suggest that the cryo-EM structure we obtained faithfully represents the overall architecture of the assembly. The cryo-EM density has features similar to negative-stained EM maps from both cross-linked and noncross-linked samples and is consistent with known crystal structures. The MS data also show a pattern we expected on the basis of earlier structural and biochemical data and new interaction sites.
In this study, we found that the UPF-EJC complex is organized into three distinct structural modules formed by a combination of domains of individual proteins: UPF2, the CH domain of UPF1 and the RRM domain of UPF3 form the central module, which is flanked on one side by the helicase region of UPF1 (the 3′ module) and on the other side by the EJC and the C-terminal domain of UPF3 (the 5′ module; Fig. 7, middle) . The central module is a ring-like structure built around UPF2, the largest subunit of the surveillance complex. The three MIF4G domains of UPF2 probably form the circular scaffold of the ring, which closes upon intermolecular and/or intramolecular interactions of the N-and C-terminal regions of UPF2 with the CH domain of UPF1. This interaction connects the central module to the helicase region of UPF1 and keeps it in an active form, as it sequesters the CH domain in a position where it cannot allosterically inhibit the unwinding activity of UPF1. In the complex, the helicase region of UPF1 is exposed and thus accessible to RNA binding. The central ring also accommodates the RRM domain of UPF3, which is recruited to the third MIF4G domain of UPF2. UPF3 connects the central module to the EJC. The major interaction occurs at the EJC-binding motif within the C terminus of UPF3. Additional contacts at the N-and C-terminal low-complexity regions of UPF3 contribute to the interaction with the EJC and possibly stabilize the orientation of the EJC relative to central module and hence to the helicase region of UPF1.
Current models of NMD envision that, in the surveillance complex, the UPF proteins are positioned at the 5′ end of the EJC, pointing toward the ribosome stalled at a premature stop codon (Fig. 7) . A minimal distance of 50 nt between the stop codon and the downstream exon-exon boundary is required to elicit EJC-dependent NMD 3, 4, 9, 11, 12 . Considering that the 3′ end of an RNA-bound EJC is 20 nt from the exon-exon boundary 13 , that the EJC itself covers 8 nt (ref. 13) and that an mRNA needs ~10 nt at the 3′ of a stop codon to exit from the ribosome 46 , it follows that the minimal physical distance between the ribosome and the EJC to elicit NMD is ~12 nt. This distance would be sufficient to account for UPF1 binding in isolation 20, 21 , but not in the context of the UPF-EJC structure. Instead, the pseudoatomic model of the UPF-EJC complex suggests that the UPF1 helicase is positioned at least 13 nt at the 3′ end of the EJC (Fig. 7, middle) . With hindsight, these findings rationalize how UPF1 is poised to unwind the 3′ end of the mRNP in the final stages of EJC-dependent NMD 21, 33 , creating the ssRNA segment required for Xrn1-mediated degradation 47 ( Fig. 7, bottom) . They also rationalize the requirement for an additional factor, the ribosomal-binding protein PYM, to remodel the EJC component of the mRNP at the 5′ end of UPF1 (ref. 48 ; Fig. 7, bottom) . These findings also raise questions and predictions. First, UPF1 associates with release factors on ribosomes terminating translation prematurely, at the 5′ end of the EJC [15] [16] [17] (Fig. 7, top) . What steps would lead to the repositioning of UPF1 from the 5′ to the 3′ end of the EJC? Is UPF1 the missing link in the 50-nt rule of NMD and, if so, is UPF1 in a helicaseon conformation when bound to the release factors? When does UPF1 phosphorylation take place and how does it affect RNA binding? What is the involvement of the large SMG1 kinase and its partners SMG-8 and SMG-9 in the initial stages of NMD 26 ? Finally, the architecture of the UPF-EJC complex predicts that large stem-loop structures in the vicinity of the EJC 3′ end would be sterically incompatible with the recruitment of the UPF proteins and would thus interfere with mRNA degradation. Notably, such a stem-loop structure has been recently identified in the case of EJC-dependent oskar mRNA localization in Drosophila melanogaster 49 .
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/.
